APA (7th ed.) Citation

Li, M., Wang, Y., Wang, X., Xiao, X., Sun, Y., Zhang, S., . . . Zhou, W. (2025). Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis. Pharmaceuticals (14248247), 18(12), 1810. https://doi.org/10.3390/ph18121810

Chicago Style (17th ed.) Citation

Li, Meng, Yi-Rong Wang, Xue Wang, Xiao-Li Xiao, Yun-Hong Sun, Sheng-An Zhang, Yan-Qi Dang, Kai Wang, and Wen-Jun Zhou. "Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis." Pharmaceuticals (14248247) 18, no. 12 (2025): 1810. https://doi.org/10.3390/ph18121810.

MLA (9th ed.) Citation

Li, Meng, et al. "Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis." Pharmaceuticals (14248247), vol. 18, no. 12, 2025, p. 1810, https://doi.org/10.3390/ph18121810.